Recent therapeutic targets in diabetic nephropathy.

Mohsen, Marwa; Elberry, Ahmed A; Mohamed Rabea, Alaa; Abdelrahim, Mohamed E A; Hussein, Raghda R S

Mohsen, Marwa; Elberry, Ahmed A; Mohamed Rabea, Alaa; Abdelrahim, Mohamed E A; Hussein, Raghda R S.

Afiliação

Mohsen M; Clinical Pharmacy Department, Faculty of Pharmacy, Beni-Suef University, Beni-Suef, Egypt.
Elberry AA; Clinical Pharmacology Department, Faculty of Medicine, Beni-Suef University, Beni-Suef, Egypt.
Mohamed Rabea A; Internal Medicine and Nephrology Department, Faculty of Medicine, Beni-Suef University, Beni-Suef, Egypt.
Abdelrahim MEA; Clinical Pharmacy Department, Faculty of Pharmacy, Beni-Suef University, Beni-Suef, Egypt.
Hussein RRS; Clinical Pharmacy Department, Faculty of Pharmacy, Beni-Suef University, Beni-Suef, Egypt.

Int J Clin Pract ; 75(11): e14650, 2021 Nov.

Article em En | MEDLINE | ID: mdl-34310818

Assuntos

Diabetes Mellitus Tipo 2; Nefropatias Diabéticas; Inibidores da Dipeptidil Peptidase IV; Glicemia; Nefropatias Diabéticas/tratamento farmacológico; Inibidores da Dipeptidil Peptidase IV/uso terapêutico; Humanos; Sistema Renina-Angiotensina

Palavras-chave

CKD; DPP-4 inhibitors; T2D; albuminuria; diabetic nephropathy

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Diabetes Mellitus Tipo 2 / Nefropatias Diabéticas / Inibidores da Dipeptidil Peptidase IV Tipo de estudo: Guideline / Risk_factors_studies Limite: Humans Idioma: En Ano de publicação: 2021 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google